Allena Pharmaceuticals, Inc. – NASDAQ:ALNA

Add to watchlist

$0.016

-0.05

-78.67%

Market closed

Open in 3 days

-38.22%

month

-35.84%

quarter

-92.19%

year

Market Cap	N/A
Enterprise value	1.33M

P/E	-0.11
EV/Sales	N/A
EV/EBITDA	-0.05
Price/Sales	N/A
Price/Book	2.01
PEG ratio	2.33
EPS	-0.31

Revenue	N/A
EBITDA	-26.63M
Income	-27.62M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA): Profit margin
Sep 2021	0	-12.69M
Dec 2021	0	5.68M
Mar 2022	0	-12.06M
Jun 2022	0	-8.55M

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA): Earnings per share (EPS)
2021-11-10	-0.18	-0.17
2022-03-31	-0.16	-0.11

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA): Debt to assets
Sep 2021	43870000	17.84M	40.67%
Dec 2021	34757000	15.88M	45.71%
Mar 2022	21732000	10.11M	46.55%
Jun 2022	17811000	14.07M	79%

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA): Cash Flow
Sep 2021	-11.47M	-185K	25.42M
Dec 2021	-12.80M	-25K	2.39M
Mar 2022	-20.03M	0	-1.05M
Jun 2022	-4.55M	0	2.25M

Allena Pharmaceuticals alternative data

Allena Pharmaceuticals
Employees

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA): Employee count
Aug 2023	12
Sep 2023	12
Oct 2023	12
Nov 2023	12
Dec 2023	12
Jan 2024	12
Feb 2024	12
Mar 2024	12
Apr 2024	12
May 2024	12
Jun 2024	12
Jul 2024	12

Allena Pharmaceuticals
Insider Trading

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA): Insider trades (number of shares)
Period	Buy	Sel
Dec 2020	0	171666
May 2021	0	25215
Nov 2021	0	40328

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	15 Nov 2021	BRENNER LOUIS MD director, officer..	Restricted Stock Units	125,582	N/A	N/A
Option	15 Nov 2021	BRENNER LOUIS MD director, officer..	Common Stock	125,582	N/A	N/A
Sale	15 Nov 2021	BRENNER LOUIS MD director, officer..	Common Stock	40,328	$0.81	$32,666
Option	10 May 2021	BRENNER LOUIS MD officer: Presiden..	Restricted Stock Units	83,721	N/A	N/A
Option	10 May 2021	BRENNER LOUIS MD officer: Presiden..	Common Stock	83,721	N/A	N/A
Sale	10 May 2021	BRENNER LOUIS MD officer: Presiden..	Common Stock	25,215	$1.11	$27,989
Sale	17 Dec 2020	BRENNER LOUIS MD officer: Presiden..	Common Stock	103,116	$1.36	$140,238
Option	17 Dec 2020	BRENNER LOUIS MD officer: Presiden..	Common Stock	247,932	N/A	N/A
Option	17 Dec 2020	WHOLIHAN EDWARD officer: Chief Financial Officer officer: Chief Financial Officer	Restricted Stock Units	164,822	N/A	N/A
Option	17 Dec 2020	WHOLIHAN EDWARD officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	164,822	N/A	N/A

ALNA insider trading transactions

Allena Pharmaceuticals
Patents

Status	Patent	Filling date	Issue date
Application	Application CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE Filling date: 17 Jun 2021 Issue date: 5 May 2022	17 Jun 2021	5 May 2022
Grant	Grant Utility: Crystallized oxalate decarboxylase and methods of use Filling date: 14 Jan 2020 Issue date: 28 Dec 2021	14 Jan 2020	28 Dec 2021
Grant	Grant Utility: Compositions, methods, and devices for dialysis Filling date: 6 Jun 2014 Issue date: 3 Aug 2021	6 Jun 2014	3 Aug 2021
Grant	Grant Utility: Recombinant uricase enzyme Filling date: 5 Nov 2019 Issue date: 27 Oct 2020	5 Nov 2019	27 Oct 2020
Application	Application RECOMBINANT URICASE ENZYME Filling date: 6 Jul 2018 Issue date: 1 Oct 2020	6 Jul 2018	1 Oct 2020
Application	Application CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE Filling date: 14 Jan 2020 Issue date: 30 Apr 2020	14 Jan 2020	30 Apr 2020
Application	Application CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE Filling date: 19 Jun 2019 Issue date: 30 Apr 2020	19 Jun 2019	30 Apr 2020
Application	Application RECOMBINANT URICASE ENZYME Filling date: 5 Nov 2019 Issue date: 5 Mar 2020	5 Nov 2019	5 Mar 2020
Grant	Grant Utility: Crystallized oxalate decarboxylase and methods of use Filling date: 14 Feb 2019 Issue date: 25 Feb 2020	14 Feb 2019	25 Feb 2020
Application	Application CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE Filling date: 14 Feb 2019 Issue date: 23 Jan 2020	14 Feb 2019	23 Jan 2020

ALNA patents

Allena Pharmaceuticals
Executives

Insider	Age	Since	Compensation
Dr. Louis Brenner (1970) Pres, Chief Executive Officer & Director	55		$823,220
Dr. Alexey L. Margolin (1953) Co-Founder & Chairman	72		$70,000

Allena Pharmaceuticals
Latest News

Friday, 29 July 2022
06:00	Hot Penny Stocks to Watch Before Market Open on July 29th	PennyStocks
Thursday, 7 July 2022
07:00	What to Know About Buying Penny Stocks on July 7th	PennyStocks
Wednesday, 29 June 2022
14:49	Why Shares Of Allena Pharmaceuticals Are Skyrocketing Today	Benzinga
11:38	ALNA Stock Alert: What to Know as Allena Pharmaceuticals Soars 200%	InvestorPlace
07:00	What to Know About Buying Penny Stocks on June 29th	PennyStocks
Thursday, 9 June 2022
07:00	What to Know About Buying Penny Stocks on June 9th	PennyStocks
Friday, 3 June 2022
19:16	Trending Penny Stocks to Watch in Early June 2022	PennyStocks
Thursday, 12 May 2022
16:12	Best Penny Stocks to Buy in May? 3 to Watch Right Now	PennyStocks
10:41	ALNA Stock Alert: 5 Things to Know as Little-Known Allena Pharmaceuticals Soars 100%	InvestorPlace
Monday, 9 May 2022
08:00	What to Know About Trading Penny Stocks on Monday, May 9th	PennyStocks
Monday, 21 March 2022
09:48	Why Are Allena Pharma Shares Plunging Today	Benzinga
Saturday, 8 January 2022
00:36	Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days	Seeking Alpha
Tuesday, 4 January 2022
06:24	Allena Stock Is Surging In Premarket Today As It Explores Strategic, Financing Alternatives	Benzinga
06:18	Allena Pharmaceuticals Stock (ALNA): Why The Price Surged Today	Pulse2
Monday, 22 November 2021
11:30	Allena Pharmaceuticals, Inc. (ALNA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now	Zacks Investment Research
11:30	After Plunging 19.7% in 4 Weeks, Here's Why the Trend Might Reverse for Allena Pharmaceuticals, Inc. (ALNA)	Zacks Investment Research
08:28	Allena Pharmaceuticals (ALNA) Sees Hammer Chart Pattern: Time to Buy?	Zacks Investment Research
Wednesday, 3 November 2021
13:15	Hot Penny Stocks to Watch as AMC and GME Go to the Moon	PennyStocks
11:10	ALNA Stock: Why The Price Surged Today	Pulse2

Ideas & Opinions

Seeking Alpha 8 Jan 2022

Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days

Frequently Asked Questions (FAQ)

What's the price of Allena Pharmaceuticals stock today?

One share of Allena Pharmaceuticals stock can currently be purchased for approximately $0.02.
When is Allena Pharmaceuticals's next earnings date?

Unfortunately, Allena Pharmaceuticals's (ALNA) next earnings date is currently unknown.
Does Allena Pharmaceuticals pay dividends?

No, Allena Pharmaceuticals does not pay dividends.
What is Allena Pharmaceuticals's stock symbol?

Allena Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "ALNA".
What is Allena Pharmaceuticals's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Allena Pharmaceuticals?

Shares of Allena Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Allena Pharmaceuticals's key executives?
Allena Pharmaceuticals's management team includes the following people:
- Dr. Louis Brenner Pres, Chief Executive Officer & Director(age: 55, pay: $823,220)
- Dr. Alexey L. Margolin Co-Founder & Chairman(age: 72, pay: $70,000)
Is Allena Pharmaceuticals founder-led company?

Yes, Allena Pharmaceuticals is a company led by its founder Dr. Alexey L. Margolin.
How many employees does Allena Pharmaceuticals have?

As Jul 2024, Allena Pharmaceuticals employs 12 workers.
When Allena Pharmaceuticals went public?

Allena Pharmaceuticals, Inc. is publicly traded company for more then 7 years since IPO on 2 Nov 2017.
What is Allena Pharmaceuticals's official website?

The official website for Allena Pharmaceuticals is allenapharma.com.
Where are Allena Pharmaceuticals's headquarters?

Allena Pharmaceuticals is headquartered at 1 Newton Executive Park Ste 202, Newton, MASSACHUSETTS.
How can i contact Allena Pharmaceuticals?

Allena Pharmaceuticals's mailing address is 1 Newton Executive Park Ste 202, Newton, MASSACHUSETTS and company can be reached via phone at +1 617 467 4577.

Allena Pharmaceuticals, Inc.

allenapharma.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.

+1 617 467 4577

1 Newton Executive Park Ste 202
Newton, MASSACHUSETTS 02462

CIK: 0001624658
ISIN: US0181191075
CUSIP: 018119107